| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Nuffield Department of Pathology, University of Oxford [S. B. F., K. C. G.], Cell Adhesion Laboratory [J. F., D. L. S.], and Molecular Oncology Unit [J. F., A. L. H.], Imperial Cancer Research Fund, Laboratories, and Molecular Immunology Group [D. G. J.], Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom; and R&D Systems Europe [I. C.] and British Biotechnology Ltd. [A. G.], Abingdon, Oxon, United Kingdom
At least 20 different isoforms of the human CD44 lymphocyte-homing receptor/hyaluronan receptor have been described to date that arise from the differential splicing of up to 10 alternative exons (termed v1v10) encoding the membrane-proximal extracellular domain. Although numerous analyses at the mRNA level have indicated tissue-specific expression of CD44 variants, few analyses have been performed at the protein level because of limited availability of suitable monoclonal antibodies. Recently, however, exon-specific monoclonal antibodies have been generated using bacterial fusion proteins, and these have been reported to detect high levels of vCD44 containing the v6 exon on human tumors. Together with earlier evidence linking this particular exon with tumor metastasis in the rat, these latter experiments have led to the interpretation that v6 splice variants play a causative role in tumor dissemination.
In this paper we describe the use of a new and comprehensive panel of CD44 exon-specific monoclonal antibodies generated against a recombinant CD44(v310)-immunoglobulin chimera to study vCD44 expression in a large number of normal and neoplastic tissues. We show that the expression of vCD44 varies greatly among different human tumors and that some express either very low levels of vCD44 or no CD44 at all. Furthermore, we demonstrate that expression is not limited to isoforms containing the v6 exon but includes variants carrying v3, v4/5, and v8/9. Additionally, normal epithelial tissues are shown to express considerable levels of these same vCD44 isoforms. Such results argue against a ubiquitous role for vCD44 isoforms in promoting tumor growth and metastasis.
1 To whom requests for reprints should be addressed, at Cell Adhesion Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, United Kingdom.
Received 12/28/93. Accepted 6/ 8/94.
This article has been cited by other articles:
![]() |
K A Voutilainen, M A Anttila, S M Sillanpaa, K M Ropponen, S V Saarikoski, M T Juhola, and V-M Kosma Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer J. Clin. Pathol., May 1, 2006; 59(5): 460 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Lossos and D. Morgensztern Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma J. Clin. Oncol., February 20, 2006; 24(6): 995 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Diaz, X. Zhou, E. T. Wright, M. Cristofanilli, T. Smith, Y. Yang, N. Sneige, A. Sahin, and M. Z. Gilcrease CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma Clin. Cancer Res., May 1, 2005; 11(9): 3309 - 3314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. McKallip, M. Fisher, U. Gunthert, A. K. Szakal, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 and Its v7 Isoform in Staphylococcal Enterotoxin B-Induced Toxic Shock: CD44 Deficiency on Hepatic Mononuclear Cells Leads to Reduced Activation-Induced Apoptosis That Results in Increased Liver Damage Infect. Immun., January 1, 2005; 73(1): 50 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krettek, G. K. Sukhova, U. Schonbeck, and P. Libby Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm: Possible Role for a Feedback Loop in Endothelial Cells Am. J. Pathol., November 1, 2004; 165(5): 1571 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sillanpaa, M. A. Anttila, K. Voutilainen, R. H. Tammi, M. I. Tammi, S. V. Saarikoski, and V.-M. Kosma CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer Clin. Cancer Res., November 1, 2003; 9(14): 5318 - 5324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Barbour, J. A. Reeder, M. D. Walsh, J. Fawcett, T. M. Antalis, and D. C. Gotley Expression of the CD44v2-10 Isoform Confers a Metastatic Phenotype: Importance of the Heparan Sulfate Attachment Site CD44v3 Cancer Res., February 15, 2003; 63(4): 887 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Skoumal, G Kolarz, G Haberhauer, J Feyertag, and A Wottawa Is soluble CD44 variant isoform 5 useful as a predicting factor and a parameter for long term observation in rheumatoid arthritis? Ann Rheum Dis, November 1, 2002; 61(11): 1036 - 1037. [Full Text] |
||||
![]() |
R. J. McKallip, Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens Int. Immunol., September 1, 2002; 14(9): 1015 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Karjalainen, R. H. Tammi, M. I. Tammi, M. J. Eskelinen, U. M. Agren, J. J. Parkkinen, E. M. Alhava, and V.-M. Kosma Reduced Level of CD44 and Hyaluronan Associated with Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma Am. J. Pathol., September 1, 2000; 157(3): 957 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Drillenburg and S. T. Pals Cell adhesion receptors in lymphoma dissemination Blood, March 15, 2000; 95(6): 1900 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jones, L. Tussey, N. Athanasou, and D. G. Jackson Heparan Sulfate Proteoglycan Isoforms of the CD44 Hyaluronan Receptor Induced in Human Inflammatory Macrophages Can Function as Paracrine Regulators of Fibroblast Growth Factor Action J. Biol. Chem., March 10, 2000; 275(11): 7964 - 7974. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Anttila, R. H. Tammi, M. I. Tammi, K. J. Syrjänen, S. V. Saarikoski, and V.-M. Kosma High Levels of Stromal Hyaluronan Predict Poor Disease Outcome in Epithelial Ovarian Cancer Cancer Res., January 1, 2000; 60(1): 150 - 155. [Abstract] [Full Text] |
||||
![]() |
A.-L. Tuhkanen, U. M. Ågren, M. I. Tammi, and R. H. Tammi CD44 Expression Marks the Onset of Keratinocyte Stratification and Mesenchymal Maturation into Fibrous Dermis in Fetal Human Skin J. Histochem. Cytochem., December 1, 1999; 47(12): 1617 - 1624. [Abstract] [Full Text] |
||||
![]() |
E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text] |
||||
![]() |
N. Ohta, H. Saito, T. Kuzumaki, T. Takahashi, M.M. Ito, T. Saito, K. Nakahara, and M. Hiroi Expression of CD44 in human cumulus and mural granulosa cells of individual patients in in-vitro fertilization programmes Mol. Hum. Reprod., January 1, 1999; 5(1): 22 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
J SPENCER Differentiating ulcerative colitis from Crohn's disease: false dawn for CD44 Gut, September 1, 1998; 43(3): 310 - 311. [Full Text] |
||||
![]() |
W Reinisch, K-H Heider, G Oberhuber, C Dejaco, M Mullner, G R Adolf, and C Gasche Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease Gut, September 1, 1998; 43(3): 375 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Claas, S. Seiter, A. Claas, L. Savelyeva, M. Schwab, and M. Zoller Association Between the Rat Homologue of CO-029, a Metastasis-associated Tetraspanin Molecule and Consumption Coagulopathy J. Cell Biol., April 6, 1998; 141(1): 267 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kogerman, M.-S. Sy, and L. A. Culp Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: Facilitated retention in the lung vasculature PNAS, November 25, 1997; 94(24): 13233 - 13238. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schmits, J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity Blood, September 15, 1997; 90(6): 2217 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Zhu, B. Nolle, and G. Duncker Expression of adhesion molecule CD44 on human corneas Br J Ophthalmol, January 1, 1997; 81(1): 80 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Spafford, J. Koeppe, Z. Pan, P. G. Archer, A. D. Meyers, and W. A. Franklin Correlation of Tumor Markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 With Survival and Metastasis in Laryngeal Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, June 1, 1996; 122(6): 627 - 632. [Abstract] [PDF] |
||||
![]() |
K. Takahashi, I. Stamenkovic, M. Cutler, A. Dasgupta, and K. K. Tanabe Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate J. Biol. Chem., April 19, 1996; 271(16): 9490 - 9496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. I. Taher, L. Smit, A. W. Griffioen, E. J. M. Schilder-Tol, J. Borst, and S. T. Pals Signaling through CD44 Is Mediated by Tyrosine Kinases J. Biol. Chem., February 2, 1996; 271(5): 2863 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nath, P. A. van der Merwe, Sør. Kelm, P. Bradfield, and P. R. Crocker The Amino-terminal Immunoglobulin-like Domain of Sialoadhesin Contains the Sialic Acid Binding Site J. Biol. Chem., November 3, 1995; 270(44): 26184 - 26191. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hudson, J Sleeman, and F. Watt CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion J. Cell Sci., January 5, 1995; 108(5): 1959 - 1970. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |